Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?

Parkinsonism and Related Disorders

Volumn 14, Issue 3, 2008, Pages 213-223

  Luquin, Natasha ^a   Mitrofanis, John ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Australian National University   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Basal ganglia; Cell death; Cortical removal; Glutamate excitotoxicity; Neuroprotection; Parkinson disease

Indexed keywords

OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN PROTECTION; CELL COUNT; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; MALE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ZONA COMPACTA;

ADRENERGIC AGENTS; ANIMALS; CELL COUNT; CELL DEATH; DECEREBRATE STATE; DOPAMINE; MALE; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 41449090987     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.08.010     Document Type: Article

References (80)

1. McRitchie D.A., and Halliday G.M. Calbindin D28k-containing neurones are restricted to the medial substantia nigra in humans. Neuroscience 65 (1995) 87-91
2. Rinne J.O. Nigral degeneration in Parkinson's disease. Mov Disord 8 Suppl 1 (1993) S31-S35
3. Langston J.W. The aetiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47 (1996) S153-S160
4. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18 (1998) 106-108
5. Albin R.L., and Greenamyre J.T. Alternative excitotoxic hypotheses. Neurology 42 (1992) 733-738
6. Beal M.F., Hyman B.T., and Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. TINS 16 (1993) 125-131
7. Blandini F., Armentero M.T., Fancellu R., Blaugrund E., and Nappi G. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Exp Neurol 187 (2004) 455-459
8. Lavoie B., and Parent A. Dopaminergic neurons expressing calbindin in normal and Parkinsonian monkeys. Neuroreport 2 (1991) 601-604
9. Piallat B., Benazzouz A., and Benabid A.L. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci 8 (1996) 1408-1414
10. Brouillet E., and Beal M.F. NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuroreport 4 (1993) 387-390
11. Turski L., Bressler K., Rettig K.J., Loschmann P.A., and Wachtel H. Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349 (1991) 414-418
12. Blandini F., Nappi G., and Greenamyre J.T. Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease. Ann Neurol 49 (2001) 525-529
13. Ashkan K., Wallace B., Bell B.A., and Benabid A.L. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 1993-2003: where are we 10 years on?. Br J Neurosurg 18 (2004) 19-34
14. Benabid A.L., Benazzouz A., and Pollak P. Mechanisms of deep brain stimulation. Mov Disord 17 Suppl 3 (2002) S73-S74
15. Hammond C., Shibazaki T., and Rouzaire-Dubois B. Branched output neurons of the rat subthalamic nucleus: electrophysiological study of the synaptic effects on identified cells in the two main target nuclei, the entopeduncular nucleus and the substantia nigra. Neuroscience 9 (1983) 511-520
16. Kita H., and Kitai S.T. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol 260 (1987) 435-452
17. Nauta H.J., and Cole M. Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat. J Comput Neurol 180 (1978) 1-16
18. Parent A., and Smith Y. Organisation of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res 436 (1987) 296-310
19. Charara A., Smith Y., and Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: phaseolus vulgaris-leucoagglutinin anterograde labelling combined with postembedding glutamate and GABA immunohistochemistry. J Comput Neurol 364 (1996) 254-266
20. Jackson A., and Crossman A.R. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience 10 (1983) 725-765
21. Saper C.B., and Loewy A.D. Projections of the pedunculopontine tegmental nucleus in the rat: evidence for additional extrapyramidal circuitry. Brain Res 252 (1982) 367-372
22. Bergman H., Wichmann T., Karmon B., and DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72 (1994) 507-520
23. Bezard E., Boraud T., Bioulac B., and Gross C.E. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. Eur J Neurosci 11 (1999) 2167-2170
24. Hollerman J.R., and Grace A.A. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res 590 (1992) 291-299
25. Hutchison W.D., Allan R.J., Opitz H., Levy R., Dostrovsky J.O., Lang A.E., et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 44 (1998) 622-628
26. Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., et al. Neural mechanisms underlying Parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32 (1989) 213-226
27. Breit S., Bouali-Benazzouz R., Benabid A.L., and Benazzouz A. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur J Neurosci 14 (2001) 1833-1842
28. Breit S., Lessmann L., Benazzouz A., and Schulz J.B. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat. Eur J Neurosci 22 (2006) 2283-2294
29. Orieux G., Francois C., Feger J., Yelnik J., Vila M., Ruberg M., et al. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neurosci 97 (2000) 79-88
30. Carvalho G.A., and Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 171 (2001) 405-417
31. Chen L., Liu Z., Tian Z., Wang Y., and Li S. Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions. Stereotact Funct Neurosurg 75 (2000) 66-75
32. Nakao N., Nakai E., Nakai K., and Itakura T. Removal of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann Neurol 45 (1999) 640-651
33. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., et al. Removal of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol 185 (2004) 272-280
34. Benabid A.L., Chabardes S., Seigneuret E., Torres N., Mitrofanis J., and Wallace B. Is deep brain stimulation in STN neuroprotective in Parkinson's disease?. Mov Disord 21 Suppl 13 (2006) S18
35. Maesawa S., Kaneoke Y., Kajita Y., Usui N., Misawa N., Nakayama A., et al. Long-term stimulation of the subthalamic nucleus in hemiParkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 100 (2004) 679-687
36. Takada M., Matsumura M., Kojima J., Yamaji Y., Inase M., Tokuno H., et al. Protection against dopaminergic nigrostriatal cell death by excitatory input removal. Eur J Neurosci 12 (2000) 1771-1780
37. Carter C.J. Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharm 21 (1982) 379-383
38. Dalsass M., Kiser S., Mendershausen M., and German D.C. Medial prefrontal cortical projections to the region of the dorsal periventricular catecholamine system. Neuroscience 6 (1981) 657-665
39. Nitsch C., Mews K., Wagner A., and Hassler R. Effects of frontal motor cortex removal on the ultrastructure of cat substantia nigra. Acta Anat 119 (1984) 193-202
40. Sakai S.T. Corticonigral projections from area 6 in the raccoon. Exp Brain Res 73 (1988) 498-504
41. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. TINS 12 (1989) 366-375
42. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124 (2001) 558-570
43. Sabatini U., Boulanouar K., Fabre N., Martin F., Carel C., Colonnese C., et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123 (2000) 394-403
44. Samuel M., Ceballos-Baumann A.O., Blin J., Uema T., Boecker H., Passingham R.E., et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 120 (1997) 963-976
45. Canavero S., Bonicalzi V., Paolotti R., Castellano G., Greco-Crasto S., Rizzo L., et al. Therapeutic extradural cortical stimulation for movement disorders: a review. Neurol Res 25 (2003) 118-122
46. Canavero S., and Paolotti R. Extradural motor cortex stimulation for advanced Parkinson's disease: case report. Mov Disord 15 (2000) 169-171
47. Canavero S., Paolotti R., Bonicalzi V., Castellano G., Greco-Crasto S., Rizzo L., et al. Extradural motor cortex stimulation for advanced Parkinson disease. Report of two cases. J Neurosurg 97 (2002) 1208-1211
48. Lefaucheur J.P. Motor cortex stimulation for Parkinson's disease and dystonia: lessons from transcranial magnetic stimulation?. Rev Neurol 161 (2005) 27-41
49. Siebner H.R., Rossmeier C., Mentschel C., Peinemann A., and Conrad B. Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. J Neurol Sci 178 (2000) 91-94
50. Orieux G., Francois C., Feger J., and Hirsch E.C. Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J Neurosci 22 (2002) 8762-8770
51. Steiner H., and Kitai S.T. Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates. Eur J Neurosci 14 (2001) 1390-1391
52. Maurice N., Deniau J.M., Glowinski J., and Thierry A.M. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci 18 (1998) 9539-9546
53. Monakow K.H., Akert K., and Kunzle H. Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 33 (1978) 395-403
54. Nambu A., Tokuno H., Hamada I., Kita H., Imanishi M., Akazawa T., et al. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 84 (2000) 289-300
55. Edley S.M., and Graybiel A.M. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J Comput Neurol 217 (1983) 187-215
56. Berger K., Przedborski S., and Cadet J.L. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res Bull 26 (1991) 301-307
57. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
58. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (2005), Elsevier Academic Press
59. George R., and Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 129 (1994) 225-236
60. Gibb W.R. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res 581 (1992) 283-291
61. Heise C.E., Teo Z.C., Wallace B.A., Ashkan K., Benabid A.L., and Mitrofanis J. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?. Anat Embryol 210 (2005) 287-302
62. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318 (2004) 215-224
63. Fitzpatrick E., Ashkan K., Wallace B.A., Benabid A.L., and Mitrofanis J. Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats. Anat Embryol 210 (2005) 101-123
64. Javoy-Agid F., Hirsch E.C., Dumas S., Duyckaerts C., Mallet J., and Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 38 (1990) 245-253
65. Bonthius D.J., McKim R., Koele L., Harb H., Karacay B., Mahony J., et al. Use of frozen sections to determine neuronal number in the murine hippocampus and neocortex using the optic disector and optical fractionator. Brain Res Prot 14 (2004) 45-57
66. Schmitz C., and Hof P.R. Design-based stereology in neuroscience. Neuroscience 130 (2005) 813-831
67. West M.J. Stereological methods for estimating the total number of neurones and synapses; issues of precision and bias. TINS 22 (1999) 51-61
68. Wright A.K., Athertin J.F., Norrie L., and Arbuthnott G.W. Death of dopaminergic neurones in the rat substantia nigra can be induced by damage to globus pallidus. Eur J Neurosci 20 (2004) 1737-1744
69. Poirier L.J., Giguere M., and Marchand R. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res Bull 11 (1983) 371-397
70. Oorschot D.E. Total number of neurones in the neostriatal., pallidal., subthalamic and substantia nigral nuclei of the rat basal ganglia: a stereological study using Cavalieri and optical disector methods. J Comput Neurol 366 (1996) 580-599
71. Hardman C.D., Henderson J.M., Finkelstein D.I., Horne M.K., Paxinos G., and Halliday G.M. Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J Comput Neurol 445 (2002) 238-255
72. Kornhuber J., Kim J.S., Kornhuber M.E., and Kornhuber H.H. The corticonigral projection: reduced glutamate content in substantia nigra following frontal cortex removal in the rat. Brain Res 322 (1984) 124-126
73. Naito A., and Kita H. The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res 637 (1994) 317-322
74. Srivastava R., Brouillet E., Beal M.F., Storey E., and Hyman B.T. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol Aging 14 (1993) 295-301
75. Temel Y, Visser-Vandewalle V, Kaplan S, Kozan R, Daemen MA, Blokland A, et al. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Res; Epub ahead of print. 2006.
76. Luquin MR, Saldise L, Guillen J, Belzunegui S, San Sebastian W, Izal A, et al. Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease? Exp Neurol 2006. published online.
77. Chen S., and Hillman D.E. Robust synaptic plasticity of striatal cells following partial deafferentation. Brain Res 520 (1990) 103-114
78. Uryu K., MacKenzie L., and Chesselet M.F. Ultrastructural evidence for differential axonal sprouting in the striatum after thermocoagulatory and aspiration lesions of the cerebral cortex in adult rats. Neuroscience 105 (2001) 307-316
79. Iacopino A.M., Quintero E.M., and Miller E.K. Calbindin-D28 K a potential neuroprotective protein. Neurodegeneration 3 (1994) 1-20
80. Drouot X., Oshino S., Jarraya B., Besret L., Kishima H., Remy P., et al. Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron 44 (2004) 769-778